Coremine Vitae applied on neuro diseasesFebruary 2020June 2020 PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs. PrevPreviousCoremine Medical upgrade NextPubGene received the Horizon 2020 Seal of ExcellenceNext previousCoremine Medical upgradenextPubGene received the Horizon 2020 Seal of Excellence